4-methoxyamphetamine has been researched along with Wallerian Degeneration in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Callaghan, PD; Daws, LC; Irvine, RJ; Javors, MA; Jones, DJ; Owens, WA; Sanchez, TA | 1 |
1 other study(ies) available for 4-methoxyamphetamine and Wallerian Degeneration
Article | Year |
---|---|
In vivo analysis of serotonin clearance in rat hippocampus reveals that repeated administration of p-methoxyamphetamine (PMA), but not 3,4-methylenedioxymethamphetamine (MDMA), leads to long-lasting deficits in serotonin transporter function.
Topics: Amphetamines; Animals; Binding, Competitive; Hippocampus; Male; Metabolic Clearance Rate; N-Methyl-3,4-methylenedioxyamphetamine; Presynaptic Terminals; Radioligand Assay; Rats; Rats, Sprague-Dawley; Serotonin; Serotonin Agents; Serotonin Plasma Membrane Transport Proteins; Synaptosomes; Wallerian Degeneration | 2007 |